Confirming the Benefit of SGLT2 Inhibitors in People With ATTR Amyloidosis, with Justin Riley Lam, MDByJustin Riley Lam, MDApril 5th 2025Lam discussed a retrospective cohort analysis he presented at the 2025 ACP IM meeting and its findings.